GMO Equity Dislocation Fund, L.P.

The absence of any prior EDGAR filings from this manager combined with eight named GPs signals a newly launched or newly SEC-registered entity, potentially spun from a larger organization or formed by a partnership of previously independent operators, each likely bringing their own LP relationships to justify the 06b exemption.

A mid-2026 amendment to a dislocation-focused hedge fund frames this as either a response to widening valuation spreads and illiquidity premiums in public markets post-correction, or a reactive pivot to capture dislocations that emerged after an initial 2025 offering window proved harder to close.

Before committing, verify whether the eight GPs are tied to key-man provisions collectively or individually, and confirm whether this amendment changed fee tiers, lock-up terms, or LP composition thresholds—material revisions often signal either that the initial target was unachievable or that terms were loosened, both of which affect fund dynamics.